Jove
Visualize
Contact Us

Related Concept Videos

Aging01:26

Aging

165
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
165
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

2.3K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.3K
Dementia01:30

Dementia

162
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
162
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

663
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
663
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

238
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
238
Mitochondria01:37

Mitochondria

14.5K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
14.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Hippocampal asymmetry captures non-amyloid-related risk of memory decline and clinical progression.

The journal of prevention of Alzheimer's disease·2026
Same journal

Tau-ing and fro-ing: the tanycytic shuttle in neurodegeneration.

The journal of prevention of Alzheimer's disease·2026
Same journal

Glymphatic dysfunction, plasma neurofilament light, and cortical free water mediate cognitive decline in familial frontotemporal lobar degeneration.

The journal of prevention of Alzheimer's disease·2026
Same journal

Distinct spatial patterns of perivascular spaces enlargement for multiple and Co-existing pathologies of cognitive impairment.

The journal of prevention of Alzheimer's disease·2026
Same journal

Drawing a line: Differentiating mild from moderate dementia using the functional activities questionnaire.

The journal of prevention of Alzheimer's disease·2026
Same journal

The generalizability gap: anticoagulant exclusions and the "Enhanced Safety" of donanemab in the EU-eligible population.

The journal of prevention of Alzheimer's disease·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Sep 4, 2025

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry
08:52

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry

Published on: April 6, 2022

3.6K

Aging, Senescence, and Dementia.

Q Behfar1, A Ramirez Zuniga, P V Martino-Adami

  • 1Pamela V. Martino-Adami, PhD., Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne. Kerpener Str. 62, 50937 Cologne, Germany, E-mail: pamela.martino-adami1@uk-koeln.de, Phone: +49-(0)221- 478-51653, Fax: +49-(0)221-478 478-98042.

The Journal of Prevention of Alzheimer'S Disease
|July 16, 2022
PubMed
Summary
This summary is machine-generated.

Cellular senescence, a hallmark of aging, contributes to neuroinflammation and Alzheimer's disease. Targeting senescent cells with senolytics offers a promising therapeutic strategy for neurodegeneration.

Keywords:
AgingAlzheimer’s diseaseneuroinflammationsenescencesenescence-associated secretory phenotype

More Related Videos

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.1K
Assessing Lysosomal Alkalinization in the Intestine of Live Caenorhabditis elegans
06:18

Assessing Lysosomal Alkalinization in the Intestine of Live Caenorhabditis elegans

Published on: April 13, 2018

6.1K

Related Experiment Videos

Last Updated: Sep 4, 2025

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry
08:52

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry

Published on: April 6, 2022

3.6K
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.1K
Assessing Lysosomal Alkalinization in the Intestine of Live Caenorhabditis elegans
06:18

Assessing Lysosomal Alkalinization in the Intestine of Live Caenorhabditis elegans

Published on: April 13, 2018

6.1K

Area of Science:

  • Neuroscience
  • Gerontology
  • Cell Biology

Background:

  • Aging involves complex biological changes, including chronic cellular stress and inflammation.
  • Cellular senescence is a key hallmark of aging, affecting various cell types including brain cells like microglia, astrocytes, and neurons.

Purpose of the Study:

  • To review current knowledge on cellular senescence.
  • To discuss the evidence of senescence in brain cells and its role in inflammaging and neurodegenerative diseases, particularly Alzheimer's disease.
  • To explore senolytics as a potential therapeutic target for Alzheimer's disease.

Main Methods:

  • Review of existing literature on cellular senescence and Alzheimer's disease.
  • Analysis of cellular changes in Alzheimer's disease and their similarity to senescence.
  • Examination of genetic risk variants and senescence-associated secretory phenotype (SASP) proteins in Alzheimer's disease patients.

Main Results:

  • Cellular changes in Alzheimer's disease resemble those of senescence across brain cell types.
  • Elevated levels of SASP proteins (IL-6, IGFBP, TGF-β, MMP-10) are found in Alzheimer's disease patients' CSF and plasma.
  • Genetic studies link Alzheimer's disease risk variants to senescence-related genes (e.g., ADAM10, ADAMTS4, BIN1).

Conclusions:

  • Cellular senescence is an emerging underlying process in Alzheimer's disease.
  • Senolytics, which eliminate senescent cells, show potential as a novel therapeutic approach for Alzheimer's disease.